An Innovative Solution to Testing Cannabis Flower, Extracts, Formulations, and Vapor/Smoke
CBDV Expands Cannabis Testing Beyond Compliance Requirements with Advanced Analytical Testing Services.
VANCOUVER, BC, CANADA, January 28 2021. Complex Biotech Discovery Ventures Ltd. (“CBDV” or the “Company”), a licensed cannabis and psilocybin research laboratory specializing in chemical analytics, extraction, and process optimization is excited to announce the launch of its new cannabis testing services that provide comprehensive analysis on cannabis smoke and vapor, plant material, and product formulations.
Embedded within the University of British Columbia, CBDV uses industry-leading instrumentation and chemical expertise to analyze cannabis material with more in-depth analysis and technology than basic compliance testing laboratories. The Company’s testing services allow cannabis producers and extractors to receive an in-depth understanding of their materials throughout each stage of the product formulation process.
Chief Executive Officer, Dr. Markus Roggen, remarked: “Our new services offer comprehensive insights into plant material, extracts, end-products and even the smoke/vapor by using state-of-the-art analytical instruments. By understanding the chemical fingerprint of the material, cannabis producers can eliminate impurities, adjust potencies, and optimize extraction processes before wasting money and resources on producing inconsistent end products. As a chemist I am really excited about adding NMR and high-res mass spectroscopy to the cannabis testing offerings.”
CBDV offers a wide variety of tests including vape/smoke analysis, NMR spectroscopy, metabolomics, nanoparticle characterization, computational modeling, and many more that can be conveniently ordered on the Company’s website.
Complex Biotech Discovery Ventures (CBDV), based at the University of British Columbia in Vancouver, BC, is a licensed cannabis and psilocybin research laboratory focused on extraction, analytical testing, and chemical process development. Founded by award-winning chemists, Dr. Markus Roggen and UBC Professor Glenn Sammis, CBDV uses precision chemical analytics and metabolomics identification to advance the cannabis and psilocybin industries.
For media and service inquiries, please contact [email protected].
Visit Advanced Analytical Testing services for more information.